The pharmacologic treatment of depression

The New England Journal of Medicine
W Z PotterH Manji

Abstract

No abstract listed.

References

May 1, 1979·The American Journal of Psychiatry·G N PandeyJ M Davis
Nov 1, 1979·The American Journal of Psychiatry·W C DuncanJ C Gillin
Oct 1, 1979·Psychiatry Research·I ExteinF K Goodwin
Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Jul 1, 1979·Archives of General Psychiatry·F QuitkinD F Klein
Jun 1, 1978·Archives of General Psychiatry·R L SpitzerE Robins
Jan 26, 1991·Lancet·G L ZornbergB M Cohen
Jun 1, 1991·The American Journal of Psychiatry·H Sternbach
Jul 1, 1991·The American Journal of Psychiatry·J M HimmelhochP Houck
Aug 1, 1990·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·O Suchowersky, J D deVries
Mar 1, 1990·Journal of Affective Disorders·J C NelsonP I Jatlow
Dec 1, 1990·Archives of General Psychiatry·E FrankV J Grochocinski
Jan 1, 1989·Archives of General Psychiatry·P R Joyce, E S Paykel
Dec 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·E S Paykel
Feb 1, 1989·Journal of Clinical Psychopharmacology·A A Nierenberg, P E Keck
Aug 18, 1989·JAMA : the Journal of the American Medical Association·K B WellsJ Ware
May 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·R P EbsteinS Kindler
Apr 1, 1989·Archives of General Psychiatry·M ZimmermanW Coryell
Sep 1, 1985·Journal of Affective Disorders·W Coryell, R Turner
Nov 1, 1987·Journal of Affective Disorders·M J GitlinN Friedfeld
Jul 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·S J CooperD J King
Feb 1, 1988·Archives of General Psychiatry·R N GoldenW Z Potter
Feb 1, 1988·Archives of General Psychiatry·M R LiebowitzD F Klein
Mar 1, 1988·Archives of General Psychiatry·J H KocsisJ Sweeney
Nov 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·J VallejoM Salamero
Jan 1, 1986·The American Journal of Psychiatry·R F Prien, D J Kupfer
Jan 1, 1986·Archives of General Psychiatry·R J KahnL M Frankenthaler
Apr 1, 1986·Cell Biochemistry and Function·K F Tipton

❮ Previous
Next ❯

Citations

Aug 1, 1996·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·R W Simms
Sep 1, 2005·European Archives of Psychiatry and Clinical Neuroscience·Louise Brådvik, Mats Berglund
Aug 22, 2003·Current Neurology and Neuroscience Reports·Karen E Anderson, Jake Mullins
Jan 1, 1995·Neuroscience and Biobehavioral Reviews·C Advokat, V Kutlesic
Jun 8, 1995·Journal of Affective Disorders·J L Claghorn, M D Lesem
Jan 1, 1996·European Psychiatry : the Journal of the Association of European Psychiatrists·M AbbarD Castelnau
Dec 14, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Michael J DetkeIstvan Bitter
Jul 1, 1996·Disease-a-month : DM·R L BarkinS J Barkin
Nov 9, 2000·European Journal of Pharmacology·M M KollerM G Humphreys-Beher
Jul 10, 2003·Journal of Psychiatric Research·Violetta KlimekGregory A Ordway
Nov 18, 2000·Mechanisms of Ageing and Development·M M KollerP J Scarpace
Jun 1, 2002·Ageing Research Reviews·Pietro GareriGiovambattista De Sarro
Aug 15, 2002·Pharmacology, Biochemistry, and Behavior·Kazushige MizoguchiTakeshi Tabira
Jan 27, 1998·Pharmacology, Biochemistry, and Behavior·T C Pellegrino, B M Bayer
Sep 3, 2002·Journal of Affective Disorders·A P Van AmerongenA Tournoux
Mar 23, 2000·Progress in Neurobiology·P GareriG De Sarro
Apr 2, 1998·General Pharmacology·P GareriG De Sarro
Oct 12, 2001·Brain Research Bulletin·C Lino-de-OliveiraF S Guimarães
Jan 26, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H EinatD Ben-Shachar
Nov 1, 1994·Baillière's Clinical Rheumatology·A T Masi
Jul 25, 2000·British Journal of Clinical Pharmacology·F J de AbajoS Schmitz
Mar 25, 1993·The New England Journal of Medicine·W Z Potter, M V Rudorfer
Oct 10, 1996·The New England Journal of Medicine·M H Levy
Jan 23, 1997·The New England Journal of Medicine·I NulmanG Koren
May 13, 1999·The New England Journal of Medicine·B P BejjaniY Agid
Aug 5, 1998·Journal of Clinical Psychopharmacology·S N Ghaemi, C K Kirkwood
Mar 2, 2005·Journal of Clinical Psychopharmacology·Michael E ThaseMichael J Detke
Aug 1, 1993·Journal of Clinical Pharmacy and Therapeutics·R B Stewart
Mar 1, 1993·International Journal of Dermatology·C S Koblenzer
Nov 1, 1993·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·A H FriedlanderL J Fitten
Aug 29, 1992·BMJ : British Medical Journal·T Walley
Jan 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·P T FrancisD M Bowen
Mar 1, 1994·The Australian and New Zealand Journal of Psychiatry·K WilhelmG Parker
Mar 1, 1994·The Australian and New Zealand Journal of Psychiatry·K WilhelmP Boyce

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Progress in Neuro-psychopharmacology & Biological Psychiatry
R A Remick
Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
A H FriedlanderL J Fitten
British Medical Journal
P C Newbold
© 2022 Meta ULC. All rights reserved